glp-1 and sarcopenia GLP-1-derived therapies sarcopenia: plea for a specific focus on at risk special populations Glucagon Like Peptide-1 Receptor Agonists
Description
Ding, X
& Mller, T

Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T
other GLP-1 RAs
/assets/images/provider/photos/2775923.jpeg)
It has also been shown to have important glucoregulatory effects, with chronic treatment in T2D individuals resulting in attenuated fasting plasma glucose levels and improved hemoglobin A1c levels [39]
